Key features at initial presentation are recurrent infections (mostly bacterial and viral ear, nose and throat (ENT) and airway infections) due to hypogammaglobulinemia and decreased IgA and/or IgM, as well as inflammatory complications and poor specific antibody responses. This evidence concerns the gene CD79A and infection.